By Nick Sohr, Managing Editor, MDBIZNews
The University of Maryland BioPark announced on Tuesday it has added two new tenants to the research campus on Baltimore’s west side.
UMB’s announcement came as BioPark and university leaders joined government officials, researchers, entrepreneurs, business leaders and academics from around the state at the BIO International Convention in Boston.
The three-day conference is the preeminent event for the biotech industry, a sector in which Maryland continues to invest significant resources.
The new BioPark tenants will bring an international touch to the campus.
BioGen is based in the United Kingdom. The molecular diagnostics company has developed a wide range of medical testing products.
GSSHealth has helped establish quality-assured laboratory testing abroad since 2008. The company is now working in Africa as well as six countries in Southeast Asia — Burma, Cambodia, China, Laos, Thailand and Vietnam.
“Having two companies with international operations select the BioPark as a primary U.S. location clearly demonstrates the tremendous growth potential for companies locating on our academic medical center campus,” said Jim Hughes, president of the BioPark.
Maryland has invested heavily in biotech sector with financing programs like the Biotechnology Investment Tax Credit and the Biotechnology Development Awards and support from the Maryland Biotechnology Center.
Biotechnology and life sciences will also be a focus of the InvestMaryland program, which in March raised $84 million that will be invested in seed-, early and growth-stage companies.